University of Oxford
Numares, Oxford University Ink License Agreement to Develop Multimarker Multiple Sclerosis Test
Numares will develop the MS test to detect the transition from relapsing remitting multiple sclerosis to secondary progressive multiple sclerosis.
Abingdon Health Inks Sales, Distribution Agreement With BioSure UK for SARS-CoV-2 Antibody Test
The lateral flow test is designed to detect immunoglobulin G antibodies against SARS-CoV-2 in a finger prick blood sample and returns results in 20 minutes.
Formerly GE Healthcare Life Sciences, Cytiva Moves Into Dx Arena to Help Startups Develop POC Tests
The company's goal is to help laboratories and smaller diagnostic firms accelerate test development and provide end-to-end test design assistance.
Prenetics Acquires Coronavirus Test Developer Oxsed
Oxsed, a University of Oxford spinout, will continue to focus on prioritizing test access for low- and middle-income countries following the acquisition.
Jul 30, 2020
UK Consortium Coronavirus Antibody Test Gets CE Mark
Mar 30, 2017